Biotechnology Congress Research Articles

European Biotechnology Congress 2023 4.6 October 2023.

European Biotechnology Congress 2023 4.6 October 2023.

Book of Abstracts - Third International Green Biotechnology Congress

Book of Abstracts - Third International Green Biotechnology Congress

Announcement of a Session on “Microbial and Food Biotechnology” Held in Iran during “4th International Biotechnology Congress”

The article abstract is not available.

World Biotechnology Congress happening in Barcelona, Spain | November 18-19, 2020

Hilaris SRL is going to host its premier World Biotechnology Congress 2020 during November 18-19, 2020, Barcelona, Spain. Biotechnology Congress aims to create a bridge between academia and industry by providing vast learning opportunities in multidisciplinary sectors and applied fields of Biotechnology. Hilaris SRL along with its World Biotechnology Congress will gather all the stakeholders of the emerging biotechnology sector and will offer the best platform to exchange knowledge and network. World Biotechnology Congress 2020 will be the premier event for Hilaris Conferences at Barcelona, which will provide a great opportunity for the stakeholders of Biotech, Pharma, and Life Sciences industry to network, establish business partnerships and will get direct access to the target audiences. Our Biotechnology 2020 Conference will provide access to key investors in the Biotechnology sectors including small & Mid Pharma, R&D companies, Innovators and key decision-makers.

Future Biotechnology

Abstract The field of biotechnology is large and could be considered tritely as simply the development of technology that is based on biology. It is clear that the concepts of biotechnology can spread to cover many different fields of application and so the future developments in biotechnology will be similarly wide-ranging across many fields of applications. Here we focus onto medical biotechnology and further refine our discussion onto considering aspects of genetics and nanotechnologies that could impact on the development of future biotechnologies in the medical field. These areas that we consider in this brief article provide the basis for a panel discussion on Future Biotechnology at the European Biotechnology Congress held in Valencia, Spain in April 2019.

12th Annual Biotechnology Congress (BAC Girona 2018): abstract collection

12th Annual Biotechnology Congress (BAC Girona 2018): abstract collection

Aerobic granular sludge – Microbial and morphological characterization

Journal of Biotechnology, vol. 231, pp. S88-S89, 2016; European Biotechnology Congress, May 2016, Latvia

Bioindicators of community structure in microalgae-bacteria processes

Journal of Biotechnology, vol. 231, pp. S89-S89, 2016; European Biotechnology Congress, May 2016, Latvia

Activated algae granulation: A biological solution for efficient microalgae harvesting

Journal of Biotechnology, vol. 208, pp. S19-S19, 2015; European Biotechnology Congress, May 2015, Bucharest

In tribute to Bernard Witholt.

It was in the mid-seventies that I met Bernard for the first time – he had just arrived in Groningen as a new professor with fresh ideas. I remember a meeting where I participated as a young student with some older Dutch professors who were, and I say this politely, not amused about the research subjects that Bernard discussed in his inspiring style. It was about Pseudomonas growing in a two-phase reactor and its application potential as well its potential for collaborations. This did not go well with the audience as Bernard provided his visionary views for microbial biotechnology in the sense that he wanted disciplines to collaborate and not remain in splendid isolation in their ivory towers. I remember being captivated by his ideas and did not agree with the displayed skepticism and accusations of modernisms of others. Fortunately, the concepts did not disappear from the agenda and in mid-eighties, the Netherlands Society for Biotechnology was founded by Bernard and other inspired colleagues. This provided the basis for further concentration of multidisciplinary activities and their spin-outs. When I became chairman of the Society about 20 years later, Bernard was at ETH Zurich and I invited him to deliver the first key note speech at the bi-annual Netherlands Biotechnology Congress. He provided his views on the innovation that originates from small research groups under the title ‘Is little science still viable’. Once again, he inspired many of us – as he did all his life.

Progress towards the ‘Golden Age’ of biotechnology in Europe. A report from the European Biotechnology Congress 2013

Progress towards the ‘Golden Age’ of biotechnology in Europe. A report from the European Biotechnology Congress 2013

The “Golden Age” of Biotechnology in Europe

ABSTRACTThe European Biotechnology Congress 2011 was held in Istanbul between the 28th of September and the 1st of October 2011. The Congress was organised by the European Biotechnology Thematic Network Association (EBTNA) in conjunction with the Turkish Medical Genetics Association and under the aegis of the Presidency of the Republic of Turkey. The Congress attracted scientists not only from Europe but from across the globe. The main topics covered by the congress were: Medical Genetics, Plant Biotechnology, Industrial Biotechnology, Animal Biotechnology, Regenerative Medicine and Stem Cells, Environmental Biotechnology, Biotechnologies in Infectious and Parasitic Diseases, Nanobiotechnology, Pharmaceutical Biotechnology, Bioinformatics, Assisted Reproductive Methods in Biotechnology, Education and Biotechnology. The application of systems biology approaches to biotechnology emerged as one of the main themes in many sections.